Europe Parenteral Nutrition Market
No. of Pages: 90 | Report Code: BMIRE00030424 | Category: Life Sciences
No. of Pages: 90 | Report Code: BMIRE00030424 | Category: Life Sciences
The Europe parenteral nutrition market was valued at US$ 2,404.63 million in 2022 and is expected to reach US$ 3,958.07 million by 2030; it is estimated to record a CAGR of 6.4% from 2022 to 2030. Surge in Cases of Malnutrition and Premature Births Drive Europe Parenteral Nutrition Market
Malnutrition includes being undernourished, overweight or obese, having inadequate vitamins or minerals, and having a non-communicable disease due to a bad diet. As per World Health Organization (WHO) data, ~1.9 billion adults were overweight or obese, whereas 462 million were underweight in 2021. Additionally, 39 million children under the age of 5 were overweight, 149 million had stunted growth and development as a result of a chronic lack of nutrient-rich food in their diets, and 45 million were wasted (too thin for height). Furthermore, ~45% of deaths among children aged less than 5 are associated with undernutrition. As per the July 2022 data of the United Nations International Children's Emergency Fund (UNICEF), the prevalence of undernourishment reached 9.3% in 2020 from 8.0% in 2019; it further jumped to 9.8% in 2021.
According to a Specialized Nutrition Europe study, ~40% of hospitalized adult patients were malnourished in Europe in 2019. As per a study titled "A multi-centre survey on hospital malnutrition," published in 2021, approximately 11-45% of patients in hospitals and home care settings in England suffered from malnutrition. Nutritional support delivered through parenteral methods, depending on the need, is an important and appropriate way of treating most malnutrition cases.
Preterm birth refers to a baby being born at a significantly early stage, i.e., before the completion of 37 weeks of pregnancy. As per the WHO data published in 2023, ~13.4 million preterm births (more than 1 in 10 births) were reported worldwide in 2020. On average, 12% of babies in low-income countries are born too early, compared to 9% in high-income countries. A large number of premature babies suffer from low weight and undeveloped immunity, which puts their lives at risk. Parenteral nutrition is preferred in preterm infants due to sucking or swallowing difficulties as a complication of an immature birth or due to neuromuscular, heart, or other disorders. When estimated energy and nutritional requirements cannot be safely met by enteral route right after birth, parenteral nutrition (PN) is part of the routine nutrition care for premature neonates and infants.
Thus, the huge burden of malnutrition in children and adults and the high number of preterm births drive the demand for parenteral nutrition formulae and products, which drives the market.Europe Parenteral Nutrition Market Overview
In Germany, there are several cases related to overweight issues, obesity, and malnutrition. According to the Robert Koch Institute, approximately two-thirds of men and over half of women were overweight in 2022. Nutritional deficiencies lead to unfavorable outcomes and lower quality of life in patients with malignancies. Patients with active tumors often lack sufficient food; hence, parenteral and enteral nutrition is used to prevent or reduce progressive weight loss. According to the Association of the Scientific Medical Societies in Germany, patients with severe gastrointestinal defects, such as radiation enteritis, can benefit from parenteral nutrition. In most cases, artificial nutrition stabilizes or increases body weight and body fat mass.
Moreover, the incidence of H. pylori infection in Germany is high, which is a significant cause of gastric cancer. According to a study (2020) in the Clinical Microbiology and Infection Journal (ELSEVIER), Helicobacter pylori infected ~25% of the total population in Germany and caused gastritis that becomes more complicated with gastric adenocarcinoma. Furthermore, Germany has a significant incidence rate of stomach cancer, which promotes diagnostic procedures in the country. According to the latest data from the International Agency for Research on Cancer, the estimated age-standardized incidence rate for stomach cancer in Germany is 7 per 100,000, and the crude rate is 18.29. The abovementioned factors are driving the parenteral nutrition market in Germany.
Europe Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)
Strategic insights for the Europe Parenteral Nutrition provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Europe Parenteral Nutrition refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Get more information on this report Europe Parenteral Nutrition Strategic Insights
Get more information on this report Europe Parenteral Nutrition Report Scope
Report Attribute
Details
Market size in 2022
US$ 2,404.63 Million
Market Size by 2030
US$ 3,958.07 Million
Global CAGR (2022 - 2030)
6.4%
Historical Data
2020-2021
Forecast period
2023-2030
Segments Covered
By Nutrient Type
By End User
Regions and Countries Covered
Europe
Market leaders and key company profiles
Get more information on this report Europe Parenteral Nutrition Regional Insights
Get more information on this report
Europe Segmentation
The Europe parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the Europe is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.
By end user, the Europe is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.
Based on country, the Europe is segmented into s. Germany dominated the Europe share in 2022.
ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG are some of the leading players operating in the Europe .
1. ICU Medical Inc
2. Grifols SA
3. Pfizer Inc
4. Otsuka Pharmaceuticals Co Ltd
5. Baxter International Inc
6. B Braun SE
7. Fresenius Kabi AG
8. Aculife Healthcare Pvt Ltd
9. Vifor Pharma Management AG
The Europe Parenteral Nutrition Market is valued at US$ 2,404.63 Million in 2022, it is projected to reach US$ 3,958.07 Million by 2030.
As per our report Europe Parenteral Nutrition Market, the market size is valued at US$ 2,404.63 Million in 2022, projecting it to reach US$ 3,958.07 Million by 2030. This translates to a CAGR of approximately 6.4% during the forecast period.
The Europe Parenteral Nutrition Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Parenteral Nutrition Market report:
The Europe Parenteral Nutrition Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Parenteral Nutrition Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Parenteral Nutrition Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Parenteral Nutrition Market
